Diabetes Mellitus, Type 2

• Celerion — Tempe, Arizona, United States
• Clinical Pharmacology of Miami, Inc. — Miami, Florida, United States
• Orlando Clinical Research Center — Orlando, Florida, United States
• Celerion — Lincoln, Nebraska, United States

• LMC Calgary — Calgary, Alberta, Canada
• LMC Barrie — Barrie, Ontario, Canada
• LMC Brampton — Brampton, Ontario, Canada
• LMC Etobicoke — Etobicoke, Ontario, Canada

• University of Alabama at Birmingham — Birmingham, Alabama, United States

Not specified

• University of California, San Diego — La Jolla, California, United States

• Tokyo, Japan

• Novo Nordisk Investigational Site — Zagreb, Croatia
• Novo Nordisk Investigational Site — Pori, Finland
• Novo Nordisk Investigational Site — Tampere, Finland
• Novo Nordisk Investigational Site — Turku, Finland

• Research Site — Berlin, Germany
• Research Site — Magdeburg, Germany
• Research Site — Mainz, Germany
• Research Site — Neu-Ulm, Germany

• Medical University of Graz, Department for Internal Medicine — Graz, Austria

• Study Site 29 — Anniston, Alabama, United States
• Study Site 26 — Birmingham, Alabama, United States
• Study Site 27 — Chula Vista, California, United States
• Study Site 28 — La Mesa, California, United States